87 related articles for article (PubMed ID: 3971684)
1. Prediction of theophylline clearance using condition correction factors.
Haumschild MJ; Murphy JE
Clin Pharm; 1985; 4(1):59-64. PubMed ID: 3971684
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Chiou method for determining theophylline dosages.
Johnson MH; Burkle WS
Clin Pharm; 1984; 3(2):174-8. PubMed ID: 6723223
[TBL] [Abstract][Full Text] [Related]
3. Rapid estimation of total body clearance of theophylline in patients receiving intravenous aminophylline infusion.
Lau AH; O'Connor T; Lam G; Lui CY; Al-Bazzaz FJ; Chiou WL
Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):12-5. PubMed ID: 3957483
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the "condition correction factor" method of estimating theophylline clearance.
Gotz VP; Russell WL; Lopez LM
Ther Drug Monit; 1983; 5(1):103-7. PubMed ID: 6845393
[TBL] [Abstract][Full Text] [Related]
5. Theophylline: constant-rate infusion predictions.
Mesquita CA; Sahebjami H; Imhoff T; Thomas JP; Myre SA
Ther Drug Monit; 1984; 6(2):157-63. PubMed ID: 6740734
[TBL] [Abstract][Full Text] [Related]
6. Reliability of theophylline clearance in determining chronic oral dosage regimens.
Slotfeldt ML; Johnson CE; Grambau G; Weg JG
Am J Hosp Pharm; 1979 Jan; 36(1):66-8. PubMed ID: 758787
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of 11 methods for predicting theophylline dose.
Rodvold KA; Paloucek FP; Zell M
Clin Pharm; 1986 May; 5(5):403-8. PubMed ID: 3720210
[TBL] [Abstract][Full Text] [Related]
8. System for clinical pharmacokinetic monitoring of theophylline therapy.
Koup JR; Schentag JJ; Vance JW; Kuritzky PM; Pyszczynski DR; Jusko WJ
Am J Hosp Pharm; 1976 Sep; 33(9):949-56. PubMed ID: 790952
[TBL] [Abstract][Full Text] [Related]
9. [Intravenous theophylline: adaptation of dosage to blood theophylline levels at admission and to clearance].
Laaban JP; Dupeyron JP; Guyon F; Drieu L; Rochemaure J; Fabiani P
Ann Med Interne (Paris); 1986; 137(5):415-9. PubMed ID: 3813276
[TBL] [Abstract][Full Text] [Related]
10. Early estimate of theophylline clearance during intravenous infusion.
Rizzo A; Mirabella A; Ferrara G; Mangiacavallo A; Bonanno A; Bonsignore G
Eur J Respir Dis; 1986 Apr; 68(4):291-7. PubMed ID: 3732424
[TBL] [Abstract][Full Text] [Related]
11. Conversion from intravenous aminophylline to sustained-release theophylline: computer simulation versus in vivo results.
Hatton RC; Gotz VP; Robinson JD; Russell WL; Ryerson GG
Clin Pharm; 1983; 2(4):347-52. PubMed ID: 6883961
[TBL] [Abstract][Full Text] [Related]
12. [Effect of enoxacin on theophylline pharmacokinetics].
Liu YN
Zhonghua Jie He He Hu Xi Za Zhi; 1992 Apr; 15(2):106-8, 128. PubMed ID: 1394590
[TBL] [Abstract][Full Text] [Related]
13. Adequacy of recommended aminophylline loading doses in children.
Maxwell-Rubin M; Paap CM; Godley PJ
Am J Hosp Pharm; 1994 Jul; 51(13):1667-71. PubMed ID: 7942891
[TBL] [Abstract][Full Text] [Related]
14. Reliability and predictive value of salivary theophylline levels.
Jaber M; Schneider AT; Goldstein S; Sergiou H; Bjornson L; Chiaramonte LT
Ann Allergy; 1987 Feb; 58(2):105-8. PubMed ID: 3813126
[TBL] [Abstract][Full Text] [Related]
15. Nonlinear regression program to individualize oral theophylline dosage.
Bauer LA; Black DJ; Koup JR
Clin Pharm; 1984; 3(3):288-90. PubMed ID: 6547379
[TBL] [Abstract][Full Text] [Related]
16. Impact of cimetidine on the pharmacokinetics of theophylline.
Schwartz JI; Bachmann KA; Bond LW; Mahajan VK
Clin Pharm; 1982; 1(6):534-8. PubMed ID: 7185539
[TBL] [Abstract][Full Text] [Related]
17. Theophylline disposition in acutely ill hospitalized patients. The effect of smoking, heart failure, severe airway obstruction, and pneumonia.
Powell JR; Vozeh S; Hopewell P; Costello J; Sheiner LB; Riegelman S
Am Rev Respir Dis; 1978 Aug; 118(2):229-38. PubMed ID: 697173
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a new lithium dosage-prediction technique.
Dugas JE; Feeney AM
Clin Pharm; 1983; 2(3):249-52. PubMed ID: 6411414
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677
[TBL] [Abstract][Full Text] [Related]
20. Rational theophylline use in older asthmatics.
Koenig HG; Blake RL
Geriatrics; 1986 Aug; 41(8):49-55. PubMed ID: 3732808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
